Talk:Small cell lung cancer

From HemOnc.org - A Hematology Oncology Wiki

Revision as of 22:08, 29 October 2019 by Karine (talk | contribs) (Caspian study)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Jump to navigation Jump to search

Hi, could you please add Caspian study? https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(19)32222-6/fulltext#seccestitle10

DO you think durvalumab will become more attractive ICP over atezolizumab due to more liberal scheduling q4 weeks?

Retrieved from "https://hemonc.org/w/index.php?title=Talk:Small_cell_lung_cancer&oldid=40777"